Worth reading
85Important
Scored from 1 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
167
SharesWording
Definitive
How definitive the wording is.This transaction
Share ExchangeCounterparty (target company)ディーブイエックス株式会社
Disclosing companyOLBA DVx HEALTHCARE,Inc.
TimelineThe spacing between the points is proportional to the actual number of days.
Consideration and expenses
Acquisition priceThe amount calculated by multiplying 167 shares by the closing price of the company's common stock on the Tokyo Stock Exchange on the purchase date (29 September 2026)
Type of ConsiderationCash
| Item | Details |
|---|---|
| Transaction name | Share Exchange |
| Counterparty name | ディーブイエックス株式会社 |
| Name of the Subject Company | ディーブイエックス株式会社 |
| Acquisition price | The amount calculated by multiplying 167 shares by the closing price of the company's common stock on the Tokyo Stock Exchange on the purchase date (29 September 2026) |
| Type of Consideration | Cash |
| Number of shares acquired | 167 shares; number of voting rights: Not disclosed |
| Date of board resolution | 29 September 2026 |
| Execution Date / Effective Date | 1 September 2026 (completed) |
Items this document does not state (24)
Business Description of the Subject CompanyLocation of the Subject CompanyCapital Stock of the Subject CompanyDate of Establishment of the Subject CompanyNet Sales of the Subject CompanyOperating Profit of the Subject CompanyNet Income of the Subject CompanyNet Assets of the Subject CompanyExpenses other than the acquisition priceMerger ratio/share exchange ratioTender offer priceMinimum number of shares to be purchasedTender offer periodVoting rights ownership percentageFunding arrangementsGoodwill amountAmount of extraordinary income (loss)Impact on Business PerformanceContract DateValuation methodologyIndependent valuation institutionSpecial CommitteeConditions Precedent to ExecutionManagement structure after acquisition
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Because fractions of less than one share arose in the company shares allocated to shareholders of DVx Inc. in connection with the share exchange, the fractions will be handled in accordance with Article 234, paragraphs 4 and 5 of the Companies Act.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.